Boyer M, Novak Z, Fraga E, Oikawa K, Kay C M, Fotedar A, Singh B
Department of Immunology, Faculty of Medicine, University of Alberta, Edmonton, Canada.
Int Immunol. 1990;2(12):1221-33. doi: 10.1093/intimm/2.12.1221.
Synthetic antigen Poly EYK(EYA)5 induces T cells of narrowly defined fine specificity as represented by the two I-Ad-restricted T cell hybridomas, A.1.1 and B.1.1. Both these hybridomas recognize the minimum 15-amino-acid peptide sequence EYK(EYA)4. We have characterized the residues involved in the recognition of EYK(EYA)4 peptide by these hybridomas with synthetic peptides and discovered a distinct functional hierarchy for the residues in the sequence. Even with the repeating tripeptide (EYA)5, which is recognized by B.1.1 cells, the residues that are essential cluster near the middle of the sequence but not near the N- or C-terminal region. Different MHC binding and TCR contacting residues were found for each of the hybridomas. The results suggest that different T cells either recognize different parts of the peptide MHC complex or that the peptide binds to MHC in multiple conformations. This was supported by the fact that Poly EYK(EYA)5 is alpha-helical but the peptides used here showed only a slight propensity to adopt this structure and it did not correlate with their functional activity. We also found that (EYA)5 does not compete with EYK(EYA)4 in the stimulation of A.1.1 cells despite its obvious capacity to interact with I-Ad when it stimulates B.1.1 cells. This may be because these peptides have a low affinity for Ia and therefore only appropriate TCR interactions would stabilize the antigen-Ia complex. In conclusion, antigen-MHC-TCR interaction appears to be a dynamic process which allows recognition of different residues of a T cell determinant by different T cells.
合成抗原聚 EYK(EYA)5 可诱导具有狭义精细特异性的 T 细胞,这由两个 I-Ad 限制性 T 细胞杂交瘤 A.1.1 和 B.1.1 所代表。这两种杂交瘤都识别最短的 15 个氨基酸的肽序列 EYK(EYA)4。我们利用合成肽对这些杂交瘤识别 EYK(EYA)4 肽所涉及的残基进行了表征,并发现该序列中残基存在明显的功能层次结构。即使是被 B.1.1 细胞识别的重复三肽(EYA)5,其必需残基也聚集在序列中部附近,而非 N 端或 C 端区域附近。每个杂交瘤都发现了不同的 MHC 结合残基和 TCR 接触残基。结果表明,不同的 T 细胞要么识别肽-MHC 复合物的不同部分,要么肽以多种构象与 MHC 结合。这一观点得到了以下事实的支持:聚 EYK(EYA)5 呈α螺旋结构,但此处使用的肽仅略有形成这种结构的倾向,且这与它们的功能活性无关。我们还发现,(EYA)5 在刺激 A.1.1 细胞时不与 EYK(EYA)4 竞争,尽管它在刺激 B.1.1 细胞时有明显的与 I-Ad 相互作用的能力。这可能是因为这些肽对 Ia 的亲和力较低,因此只有适当的 TCR 相互作用才能稳定抗原-Ia 复合物。总之,抗原-MHC-TCR 相互作用似乎是一个动态过程,允许不同的 T 细胞识别 T 细胞决定簇的不同残基。